These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6103797)

  • 1. Antinuclear antibodies and cardiovascular drugs.
    Wilson JD
    Drugs; 1980 Apr; 19(4):292-305. PubMed ID: 6103797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa].
    Homberg JC; Abuaf N; Plouin PF; Ménard J; Fillastre JP
    J Pharmacol; 1983; 14 Suppl 2():61-6. PubMed ID: 6138472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANA and antihypertensive drugs. Any clinical importance?
    Kristensen BO
    Dan Med Bull; 1987 Dec; 34 Suppl 1():18-20. PubMed ID: 3501748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic-receptor blockers and antinuclear antibodies in hypertension.
    Booth RJ; Wilson JD; Bullock JY
    Clin Pharmacol Ther; 1982 May; 31(5):555-8. PubMed ID: 6122525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of acebutolol-induced antinuclear antibodies.
    Querin S; Feuillet-Fieux MN; Jacob L; Niel G; Bach JF
    J Immunopharmacol; 1986; 8(4):633-49. PubMed ID: 3492566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.
    Singsen BH; Fishman L; Hanson V
    Pediatrics; 1976 Apr; 57(4):529-34. PubMed ID: 1083501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies in patients receiving non-practolol beta-blockers.
    Wilson JD; Bullock JY; Sutherland DC; Main C; O'Brien KP
    Br Med J; 1978 Jan; 1(6104):14-6. PubMed ID: 23197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic antidepressant and cardiovascular drug interactions.
    Thornton WE
    Am Fam Physician; 1979 Jul; 20(1):97-9. PubMed ID: 36740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prazosin on the development of antinuclear antibodies in hypertensive patients.
    Wilson JD; Bullock JY; Booth RJ
    Clin Pharmacol Ther; 1979 Aug; 26(2):209-12. PubMed ID: 37015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of antinuclear antibody tests in children.
    McGhee JL; Kickingbird LM; Jarvis JN
    BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of antinuclear antibodies (ANA) detected by indirect immunofluorescence assay (IFA) method.
    Karamehic J; Subasic D; Gavrankapetanovic F; Zecevic L; Eminovic I; Memic S; Seric N; Drace Z
    Med Arh; 2007; 61(1):16-9. PubMed ID: 17582968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
    Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
    Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
    J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.